Chemoinformaics analysis of Silane, 1,4-phenylenebis[trimethyl-
| Molecular Weight | 222.48 | nRot | 2 |
| Heavy Atom Molecular Weight | 200.304 | nRig | 6 |
| Exact Molecular Weight | 222.126 | nRing | 1 |
| Solubility: LogS | -6.664 | nHRing | 0 |
| Solubility: LogP | 5.035 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
| nHA | 0 | APOL | 45.7694 |
| nHD | 0 | BPOL | 52.9506 |
| QED | 0.675 |
| Synth | 2.552 |
| Natural Product Likeliness | -0.027 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.007 |
| Pgp-sub | 0.005 |
| HIA | 0.071 |
| CACO-2 | -4.946 |
| MDCK | 0.000016 |
| BBB | 0.021 |
| PPB | 0.829743 |
| VDSS | 2.042 |
| FU | 0.270769 |
| CYP1A2-inh | 0.708 |
| CYP1A2-sub | 0.989 |
| CYP2c19-inh | 0.029 |
| CYP2c19-sub | 0.847 |
| CYP2c9-inh | 0.01 |
| CYP2c9-sub | 0.47 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.252 |
| CYP3a4-inh | 0.012 |
| CYP3a4-sub | 0.353 |
| CL | 2.558 |
| T12 | 0.376 |
| hERG | 0.119 |
| Ames | 0.014 |
| ROA | 0 |
| SkinSen | 0.603 |
| Carcinogencity | 0.018 |
| EI | 0.995 |
| Respiratory | 0.61 |
| NR-Aromatase | 0.013 |
| Antiviral | Yes |
| Prediction | 0.635634 |